• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK SURPASS 3X20; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK SURPASS 3X20; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Catalog Number M003101FPP0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Dysphasia (2195)
Event Date 03/22/2018
Event Type  Injury  
Manufacturer Narrative
This is report 1 of 2.The device history record review confirms that the device met all material, assembly and performance specifications.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.Stroke and patient complications (speech difficulties/ dysphasia) are known risks associated with endovascular procedures and is noted as such in the device directions for use (dfu); therefore, anticipated in nature.Therefore, an assignable cause of anticipated procedural complications was assigned to this event.Subject device remains implanted.
 
Event Description
During the stenting procedure for one fusiform ica (internal carotid artery)-m1 mca (middle cerebral artery) aneurysm, it was reported that difficulty was encountered when unsheathing the stent.However, two stents were implanted successfully and post-procedure, modified rankin scale (mrs) was 3.Then the next day post procedure the patient had small embolic infarcts in the left anterior circulation hemisphere and mca territory infarction at insular cortex (l.Sin).In addition, ct (computed tomography), mra (magnetic resonance angiogram), and mri (magnetic resonance angiogram) on the same day showed infarct.Approximately 6 days post procedure, the patient was discharged from the intensive care and admitted to the neurology ward with continuing clopidogrel daily.According to the physician, the adverse event was related to the procedure and the implanted flow diverter.Six months post-procedure, the patient was still hospitalized and difficulties of speech has increased.No further information is available for now.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURPASS 3X20
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key7916866
MDR Text Key121992034
Report Number3008881809-2018-00420
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
P170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 09/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Catalogue NumberM003101FPP0
Device Lot Number19678821
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/04/2018
Initial Date FDA Received09/27/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age33 YR
Patient Weight83
-
-